ArticleHealth science reports2026
A Review of Respiratory Infection Caused by the Human Metapneumovirus: Occurrence, Epidemiology, Pathogenesis, Public Health Outcomes, and Intervention Strategies.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Human metapneumovirus (hMPV) is a leading cause of acute respiratory tract infections, particularly in children, older adults, and individuals with immunocompromising conditions. Despite increasing global recognition of its clinical relevance, a comprehensive understanding of hMPV's epidemiology, pathogenesis, and intervention strategies remains limited. This review aims to summarize recent advances in hMPV research, highlight knowledge gaps, and outline future directions for research and public health preparedness. Methods: We conducted a structured narrative review of peer-reviewed literature on hMPV published between 2001 and 2025, with emphasis on recent studies (2015-2024). Databases searched included Google Scholar, PubMed, Scopus, and Web of Science. Articles were selected based on relevance to epidemiological patterns, clinical features, diagnostic approaches, molecular virology, immunopathogenesis, and intervention strategies, including vaccine development. Results: hMPV exhibits global circulation with distinct seasonal and regional patterns. Clinical manifestations often mimic other respiratory viruses, making differential diagnosis challenging. Although no licensed vaccine or specific antiviral treatment currently exists, significant advances have been made in vaccine research, including live-attenuated, subunit, and mRNA-based platforms. Public health measures, including hygiene practices, surveillance, and community-level interventions, have demonstrated effectiveness, particularly in low-resource settings. Geographic disparities in diagnostic capacity and vaccine research highlight the need for more equitable global responses. Conclusion: hMPV represents a substantial yet underrecognized burden on global respiratory health. While progress in understanding its molecular biology and vaccine development is encouraging, further research is needed to tailor interventions to diverse populations and the varying capacities of health systems. Strengthened surveillance, global equity in vaccine access, and improved awareness are critical to mitigating the long-term public health impact of hMPV. The recent outbreaks of hMPV in China stress the urgency of these measures and the need to prioritize the development of effective vaccines and antiviral therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.